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Background
Aicardi-Goutières syndrome (AGS) is a genetic disease,
characterized by encephalopathy with cerebral calcifica-
tion, white matter abnormalities, cerebral atrophy, elevated
interferon-alpha in the cerebrospinal fluid and chilblain.
Most of AGS patients have severe neurological findings
including developmental delay. Five genes, namely TREX1,
RNASEH2B, RNASEH2C, RNASEH2A, SAMHD1 have
been reported to be responsible for AGS. Most cases of
AGS are inherited as autosomal recessive manner,
although autosomal dominant AGS is rarely reported and
its clinical manifestations are largely unknown.
Aim
We found a three-generation Japanese family whose
members shared severe chilblain in an autosomal domi-
nant manner. We tried to identify the responsible gene
and investigated genotype-phenotype correlation within
the family.
Methods
We performed sequencing of the genes responsible for
AGS and obtained clinical information from the family.
Results
The proband had severe chilblain, mental retardation, cer-
ebral calcification, and elevated serum interferon-alpha.
We identified a heterozygous TREX1 mutation, D18N
(52G>A) and diagnosed her as AGS. Her mother had the
same D18N mutation, although she lacked neurological
impairments and cerebral calcification was comparable to
the age-matched controls. We diagnosed her mother as
familial chilblain lupus (FCL). The proband’s nephew also
shared the same D18N mutation with neurological
abnormalities including mental retardation and epilepsy.
However, he lacked cerebral calcification and chilblain.
These data indicated that the same TREX1 mutation
D18N caused AGS, FCL, and the neurological disorder
without brain calcification in the same family.
Conclusion
It should be alerted that autosomal dominant TREX1
mutation D18N has clinical variation when performing
genetic test for AGS/FCL.
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